Indian Bortezomib Exporters: Complete Supplier Ranking with Market Share — 200 Manufacturers (2026) — TransData Nexus

Q: Who is the largest bortezomib supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the largest bortezomib exporter from India with a 32.0% market share and export value of $7.0M.

Q: How many bortezomib suppliers are there in India?

There are 200 active bortezomib exporters in India, collectively shipping $21.9M worth of bortezomib across 1,383 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top bortezomib suppliers from India?

The top 5 bortezomib suppliers from India — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, VENUS REMEDIES LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together control 74.4% of total bortezomib export value from India.

Suresh Sormare

Bortezomib

India Pharmaceutical Trade Intelligence

$21.9M200 Suppliers109 CountriesHS 30049049

ExportsIndia → BRAZIL28.3%India → UNITED STATES25.4%

ImportsITALY → India$200.0K UNITED STATES → India$72.1K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: EUGIA US

Bortezomib Suppliers from India (2026) — 200 Exporters, $21.9M Market | TransData Nexus | TransData Nexus

Who Exports Bortezomib from India — 200 Suppliers Behind a $21.9M Market

India's bortezomib export market is supplied by 200 active exporters who collectively shipped $21.9M across 1,383 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 32.0% market share, followed by EUGIA PHARMA SPECIALITIES LIMITED and MSN LABORATORIES PRIVATE LIMITED. The top 5 suppliers together control 74.4% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published May 2026

India's Top Bortezomib Suppliers & Exporters — 200 manufacturers, $21.9M export market, top destinations and formulations — Bortezomib supplier data — 200 exporters · $21.9M market · 1,383 shipmentsTransData Nexus · Indian Customs Data

Top Bortezomib Exporters from India — Ranked by Export Value

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading bortezomib exporter from India, holding a 32.0% share of the $21.9M market across 1,383 shipments from 200 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, VENUS REMEDIES LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — collectively control 74.4% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (32.0%), EUGIA PHARMA SPECIALITIES LIMITED (18.4%), MSN LABORATORIES PRIVATE LIMITED (16.4%), VENUS REMEDIES LIMITED (4.0%), FRESENIUS KABI ONCOLOGY LIMITED (3.7%).

Top Bortezomib Exporters from India

Ranked by export value · 200 active suppliers · Indian Customs (DGFT) data

May 2026

Top Bortezomib Exporters from India — Ranked by Export Value. 200 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Bortezomib — Export Intelligence Video

Visual overview of India's bortezomib supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's bortezomib pharmaceutical supplier landscape — $21.9M in total trade, 200 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Bortezomib exporters

Certification and compliance status for top Bortezomib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Not Listed	Yes, as of February	No	Not verified	WHO-GMP certified as of February 2015.
EUGIA PHARMA SPECIALITIES LIMITED	Not Listed	Yes, as of November	No	Not verified	WHO-GMP certified as of November 2025.
MSN LABORATORIES PRIVATE LIMITED	Approved	Yes, as of February	No	1	FDA-approved ANDA for Lacosamide; WHO-GMP certified as of February 2015.
VENUS REMEDIES LIMITED	Not Listed	Yes, as of November	No	Not verified	WHO-GMP certified as of November 2025.
GLENMARK PHARMACEUTICALS LIMITED	Not Listed	Yes, as of February	No	Not verified	WHO-GMP certified as of February 2015.
DR. REDDY'S LABORATORIES LIMITED	Approved	Yes, as of February	No	Not verified	FDA-approved; WHO-GMP certified as of February 2015.
GLAND PHARMA LIMITED	Not Listed	Yes, as of February	No	Not verified	WHO-GMP certified as of February 2015.
SP ACCURE LABS PRIVATE LIMITED	Not Listed	Yes, as of February	No	Not verified	WHO-GMP certified as of February 2015.

TransData Nexus reviewed the regulatory standing of 8 leading Bortezomib exporters from India. 2 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Bortezomib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Pharma City of India," is a pivotal hub for bulk drug production. The city contributes nearly 40% of the country's bulk drug output and hosts over 2,000 pharmaceutical companies. This concentration is bolstered by initiatives like the Hyderabad Pharma City project, aimed at creating a comprehensive ecosystem for pharmaceutical manufacturing and research. Notably, companies such as Gland Pharma, headquartered in Hyderabad, have been instrumental in the production and export of Bortezomib.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its prowess in pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. The region is home to major pharmaceutical firms like Alembic Pharmaceuticals, which has a significant presence in Vadodara. These companies are key players in the formulation and export of Bortezomib, leveraging the region's robust infrastructure and skilled workforce.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Bortezomib exporters from India

June 24, 2024

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma Completes Taro Merger

Sun Pharma completed the merger with Taro Pharmaceutical Industries Ltd., acquiring all outstanding ordinary shares of Taro, making it a wholly-owned subsidiary. - IMPACT: This consolidation may enhance Sun Pharma's manufacturing capabilities, potentially increasing Bortezomib production and export capacity.

Impact: This consolidation may enhance Sun Pharma's manufacturing capabilities, potentially increasing Bortezomib production and export capacity.

January 10, 2024

Capacity Expansion

Eugia Pharma Specialities Limited — Aurobindo Pharma Plans Eugia Pharma IPO to Raise Rs 4,500 Crore

Aurobindo Pharma is exploring an IPO for its subsidiary, Eugia Pharma Specialities, aiming to raise approximately Rs 4,500 crore to enhance operational efficiency and fund strategic initiatives. - IMPACT: The capital infusion could bolster Eugia's production capabilities, potentially increasing Bortezomib exports.

Impact: The capital infusion could bolster Eugia's production capabilities, potentially increasing Bortezomib exports.

Common Questions — Bortezomib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which bortezomib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 57 recorded shipments worth $7.0M. EUGIA PHARMA SPECIALITIES LIMITED (69 shipments) and MSN LABORATORIES PRIVATE LIMITED (97 shipments) are also established high-volume exporters.

Q How many bortezomib manufacturers are there in India?

India has 200 active bortezomib exporters with a combined export market of $21.9M across 1,383 shipments to 109 countries. The top 5 suppliers hold 74.4% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for bortezomib from India?

Average FOB unit price: $37.04 per unit, ranging from $0.05 to $1081.57. Average shipment value: $15.8K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Bortezomib

Bortezomib

Who Exports Bortezomib from India — 200 Suppliers Behind a $21.9M Market

Top Bortezomib Exporters from India — Ranked by Export Value

Top Bortezomib Exporters from India

Related Analysis

Need Details?

Bortezomib — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma Completes Taro Merger

Eugia Pharma Specialities Limited — Aurobindo Pharma Plans Eugia Pharma IPO to Raise Rs 4,500 Crore

Common Questions — Bortezomib Suppliers from India

Q Which bortezomib supplier from India is the most reliable for bulk orders?

Q How many bortezomib manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for bortezomib from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Limited — FDA Issues Warning Letter to Sun Pharma

Analysis Methodology